Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Music as a Nonpharmacologic Approach to Pain Control With Intrauterine Device Placement

13 juillet 2022 mis à jour par: Melissa Lozano, Icahn School of Medicine at Mount Sinai

The intervention of this study is the addition of patient-selected music during IUD insertion procedure. Subjects randomized to the music group will choose 10 songs, which will be played during the procedure, from the time of positioning through completion of IUD insertion and speculum removal. Music may be played through a portable speaker in close proximity to the patient or through the patient's own headphones, if preferred. Music will be played at a low enough volume for subjects to hear standard anticipatory guidance during the procedure. Both control and music groups will otherwise undergo the same standard protocol for IUD insertion in an outpatient clinic setting. Total participation is predicted to last approximately 30 minutes.

Subjects in both control and intervention groups will undergo the same assessment of pain during IUD insertion using the 100-mm visual analog scale (VAS). This will be administered at 8 points during the procedure. All subjects will also answer the same 5-question satisfaction survey following IUD insertion. Pain scores will be measured and compared between music and control groups to assess the primary and secondary outcomes of this study.

Aperçu de l'étude

Statut

Résilié

Les conditions

Intervention / Traitement

Description détaillée

This is a prospective, two-center, randomized controlled trial evaluating whether music reduces pain and improves satisfaction during IUD insertion. Computer-generated randomization assignments will allocate subjects to either music or standard protocol groups. 40 music and 40 control designations will be allocated to both sites, and all designations will be block-stratified into 10 blocks, each containing 4 controls and 4 intervention (music) subjects. This will ensure there are close to equal numbers of subjects in both groups if recruitment is halted before the minimum of 80 patients are enrolled. Assignments are available in a read-only document accessible by all co-investigators at the time of enrollment and randomization.

Subjects randomized to the music group will choose 10 songs, which will be played during the procedure, from the time of positioning through completion of IUD insertion and speculum removal. Music may be played through a portable speaker in close proximity to the patient or through the patient's own headphones, if preferred. Both control and music groups will otherwise undergo the same standard anticipatory guidance and protocol for IUD insertion in an outpatient clinic setting. Total participation is predicted to last approximately 30 minutes, as is standard for an appointment for IUD insertion. Study subjects will not interact with other participants.

Patients in both control and intervention groups will undergo intrauterine device (IUD) insertion. Pain will be assessed using a 100-mm visual analog scale (VAS) at 8 points during the procedure, including: (1) anticipated pain, (2) baseline pain prior to IUD insertion, (3) after speculum placement, (4) on tenaculum application, (5) on uterine sounding, (6) at IUD insertion, (7) after speculum removal, and (8) 5 minutes following the procedure. Patients will also answer a brief 5-question satisfaction survey following IUD insertion. Pain scores will be measured and compared between music and control groups to assess the primary and secondary outcomes of this study.

VAS scores will be recorded by the attending physician or co-investigator, as they will reliably note when each step of the procedure occurs and pain should be assessed. They will present the 100mm visual analog scale (VAS) to the patient at each of the 8 points of the procedure, and the patient will mark their pain score. Scores will be measured and documented by a single co-investigator to eliminate bias or differences in measurement.

VAS scores will be analyzed separately for each of the 8 distinct points described during the IUD insertion procedure. Differences between the intervention (music) and control groups will be assessed using a 0.05 level Wilcoxon ranksum test. A significant difference in pain will be noted if at least a 20 mm difference in VAS pain score exists between the two groups at any point of the procedure when VAS score is collected.

The aim of this study is to determine if music, chosen by the patient and played during IUD insertion, leads to lower pain scores and improved patient satisfaction with the procedure.

Type d'étude

Interventionnel

Inscription (Réel)

8

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • New York
      • New York, New York, États-Unis, 10019
        • Mount Sinai West
      • New York, New York, États-Unis, 10003
        • Mount Sinai Beth Israel

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Provision of signed and dated informed consent form
  • Nulliparous adult females age 18 years or older (nulliparous is defined as no prior pregnancies greater than or equal to 20 weeks of gestation)
  • English-speaking patients
  • Undergoing insertion of a copper or levonorgestrel intrauterine device
  • Willing to comply with all study procedures

Exclusion Criteria:

  • Non-English speaking patients
  • Patients with a support person in the room during IUD insertion
  • Patients desiring a paracervical block for analgesia

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Diagnostique
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Music Intervention group
Subjects randomized to the music group will choose 10 songs, which will be played during the procedure, from the time of positioning through completion of IUD insertion and speculum removal. Participants will otherwise undergo standard protocol for IUD insertion in an outpatient clinic setting. Total participation is predicted to last approximately 30 minutes.
Music may be played through a portable speaker in close proximity to the patient or through the patient's own headphones, if preferred. Music will be played at a low enough volume for subjects to hear standard anticipatory guidance during the procedure.
Aucune intervention: Control group
Participants to undergo same standard protocol for IUD insertion in an outpatient clinic setting. No music will be played during the procedure.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
100-mm visual analog scale (VAS)
Délai: Day 1, at time of IUD insertion
100-mm VAS total scale from 1-100 with higher score indicating more pain
Day 1, at time of IUD insertion

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
100-mm visual analog scale (VAS)
Délai: Day 1, baseline prior to IUD insertion
100-mm VAS total scale from 1-100 with higher score indicating more pain
Day 1, baseline prior to IUD insertion
100-mm visual analog scale (VAS)
Délai: Day 1, after speculum placement
100-mm VAS total scale from 1-100 with higher score indicating more pain
Day 1, after speculum placement
100-mm visual analog scale (VAS)
Délai: Day 1, on tenaculum application
100-mm VAS total scale from 1-100 with higher score indicating more pain
Day 1, on tenaculum application
100-mm visual analog scale (VAS)
Délai: Day 1, on uterine sounding
100-mm VAS total scale from 1-100 with higher score indicating more pain
Day 1, on uterine sounding
100-mm visual analog scale (VAS)
Délai: Day 1, after speculum removal
100-mm VAS total scale from 1-100 with higher score indicating more pain
Day 1, after speculum removal
100-mm visual analog scale (VAS)
Délai: Day 1, 5 minutes following the procedure
100-mm VAS total scale from 1-100 with higher score indicating more pain
Day 1, 5 minutes following the procedure
Patient Satisfaction Survey
Délai: Day 1, post procedure at 30 minutes
Patient Satisfaction Survey consists of 5-question administered post-procedure. Full scale from 1 to 5, with higher score indicating higher satisfaction.
Day 1, post procedure at 30 minutes

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Neha R Bhardwaj, MD, Icahn School of Medicine at Mount Sinai

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

14 décembre 2020

Achèvement primaire (Réel)

16 novembre 2021

Achèvement de l'étude (Réel)

16 novembre 2021

Dates d'inscription aux études

Première soumission

5 avril 2021

Première soumission répondant aux critères de contrôle qualité

5 avril 2021

Première publication (Réel)

8 avril 2021

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

15 juillet 2022

Dernière mise à jour soumise répondant aux critères de contrôle qualité

13 juillet 2022

Dernière vérification

1 juillet 2022

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • IRB-20-03749

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner